2023 Form 5500 filing — C4 Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240726084543NAL0010042611001) for C4 Therapeutics, Inc. 401(K) Plan, reported by C4 Therapeutics, Inc. under EIN 47-5617627 and plan number 001. It reports 188 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20240726084543NAL0010042611001
Filing year
2023
Form type
2
Plan sponsor
C4 Therapeutics, Inc.
EIN
47-5617627
Plan number
001
Location
Watertown, MA
Participants
188
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$21,636,909
Total liabilities (EOY)
$0
Net assets (EOY)
$21,636,909
Employer contributions
$1,149,305
Participant contributions
$2,669,519
Total income / additions
$8,536,996
Benefits paid
$773,089
Administrative expenses
$4,975
Total expenses
$781,156
Net increase / (decrease)
$7,755,840
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalRECORDKEEPER$4,975$0

Related Form 5500 pages